Systemic immune-inflammation index holds high prognostic value in patients undergoing Bacillus Calmette-Guerin -immunotherapy for bladder cancer
Main Authors: | Zhaoxiang Wang, Yuntian Chen, Jiaming Liu, Peng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-02-01
|
Series: | Asian Journal of Surgery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958421007259 |
Similar Items
-
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer
by: Po-Ting Lin, et al.
Published: (2023-02-01) -
Successful treatment with low‐dose oral steroids for contracted bladder after intravesical instillation of Bacillus Calmette–Guérin
by: Akinobu Katami, et al.
Published: (2024-03-01) -
Bladder Contracture – A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy
by: Cindy Garcia, et al.
Published: (2016-01-01) -
A case of mycotic infrarenal abdominal aortic aneurysm after bacillus Calmette-Guérin immunotherapy for bladder cancer and a review of the literature
by: Vinojan Satchithanantham, MD, FEBVS, FRCSEd, et al.
Published: (2023-09-01) -
Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk
by: Ugo Fedeli, et al.
Published: (2021-02-01)